KMTS

KESTRA MED TECHNOLOGIES LTD

KMTS·G52441105·US·Common Stock·Healthcare - Medical Instruments & Supplies-13D/G

KMTS (KESTRA MED TECHNOLOGIES LTD) is held by 68 institutional investors as of Q1 2026. Largest holders: PRICE T ROWE ASSOCIATES INC /MD/ ($119M), FMR LLC ($114M), ALLIANCEBERNSTEIN L.P. ($35M). Net institutional sentiment: Mixed.

68
Holders
Avg rating(15 Elite)
$503.1M
Total Value
64% (78)
Fund Consensus
45 buying - 25 selling
KMTSSmart Money Verdict
View all
Held by 68 funds
15 elite
Who's Trading
InsiderWDWebster Brian DanielSell $301KApr 15, 2026
ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.10.2%Apr 8, 2026
InsiderCWCOHEN RAYMOND WBuy $200KMar 26, 2026
InsiderWDWebster Brian DanielSell $304KMar 17, 2026
InsiderWDWebster Brian DanielSell $295KFeb 17, 2026
ActivistEMEndeavour Medtech Growth II LP4.2%Feb 17, 2026
InsiderWDWebster Brian DanielSell $86KFeb 17, 2026
InsiderWDWebster Brian DanielSell $3KFeb 17, 2026
ActivistBCBain Charger Holdings, L.P.43.1%Feb 17, 2026
InsiderWDWebster Brian DanielSell $342KJan 15, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6M(+36.6%)$119M0.0%+5.44%
39
Decreased
5.7M(-2.2%)$114M0.0%+11.63%
0
Decreased
1.3M(-7.4%)$35M0.0%+13.33%
0
Increased
1.7M(+2.1%)$34.4M0.1%+7.42%
30
Increased
1.7M(+36.8%)$33.7M0.0%+21.68%
38
Increased
1.2M(+30.7%)$24.8M0.0%+5.35%
36
New
1.2M$24.2M0.0%+13.39%
40
Increased
671,112(+53.9%)$13.4M0.0%+13.27%
39
Increased
655,877(+17.0%)$13.1M0.1%+7.24%
39
Increased
573,925(+36.9%)$11.4M0.0%+23.95%
36
Unchanged
525,000$10.5M0.0%+7.07%
0
Decreased
447,315(-3.4%)$8.9M0.1%-3.63%
0
Increased
349,687(+29.5%)$7M0.0%+10.29%
34
Increased
288,354(+5.8%)$5.7M0.0%+1.77%
29
Increased
237,116(+22.6%)$4.7M0.0%+8.13%
32
New
218,827$4.4M0.0%+13.39%
37
Decreased
197,491(-9.1%)$3.9M0.0%+11.01%
0
Increased
191,609(+44.7%)$3.8M0.0%+24.09%
36
Increased
172,174(+44.0%)$3.4M0.0%+29.86%
36
New
145,697$2.9M0.0%+13.39%
36

Showing 1-20 of 78

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used